Does Type of Bolus Insulin Matter in the Hospital? Retrospective Cohort Analysis of Outcomes Between Patients Receiving Analogue Versus Human Insulin
Does Type of Bolus Insulin Matter in the Hospital? Retrospective Cohort Analysis of Outcomes Between Patients Receiving Analogue Versus Human Insulin
复制标题
DOI:
10.1016/j.clinthera.2010.10.009
复制
发表时间:
2010-10-01
影响因子:
3.2
通讯作者:
Dubois, Robert W.
中科院分区:
文献类型:
--
作者:
Ko, Kelly J.;Tomor, Veronica;Dubois, Robert W.
Background: Poor glycemic control in hospitalized patients has been associated with increased morbidity and mortality. Research suggests that analogue bolus insulin may be more effective in achieving blood glucose (BG) control compared with human bolus insulin.Objective: This study compares mortality, length of stay (LOS), costs, and BG control in hospitalized patients receiving either analogue or human bolus insulin.Methods: This retrospective cohort analysis used data from January 1, 2004, to December 31, 2007, within the Health Facts database (Cerner Corporation, Kansas City, Missouri). Nonsurgical adult patients who received exclusively analogue or human bolus insulin during hospitalization were included in the study. Propensity score matching and multivariate regression analyses were used to compare patients treated with analogue versus human bolus insulin. The study outcomes were in-hospital mortality, hospital LOS among survivors (to avoid potentially short hospitalizations among nonsurvivors distorting results), and hospitalized BG control (present vs absent), defined as having a mean BG of 70 to